CytomX Therapeutics, Inc. (CTMX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $1.05B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-196.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $1.05B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $102.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $810.84M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $111.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $789.72M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $104.00K.
CytomX Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $2.00K | $1.05B | $-196.00K | $-750.86M | $302.07M | 3 month · $2.58M | (m) | (m) |
| 2026-03-31 | $0.00 | $2.00K | $1.05B | $102.00K | $-730.20M | $319.94M | 3 month · $4.71M | 3 month · $5.86M | (m) |
| 2025-12-31 | $0.00 | $2.00K | $810.84M | $111.00K | $-711.95M | $99.01M | 12 month · $6.30M | (m) | (m) |
| 2025-09-30 | $0.00 | $2.00K | $789.72M | $104.00K | $-682.44M | $107.39M | 3 month · $1.38M | (m) | (m) |
| 2025-06-30 | $0.00 | $2.00K | $788.08M | $33.00K | $-668.21M | $119.91M | 3 month · $1.43M | (m) | (m) |
| 2025-03-31 | $0.00 | $1.00K | $693.10M | $-1.00K | $-668.05M | $25.05M | 3 month · $2.01M | (m) | (m) |
| 2024-12-31 | $0.00 | $1.00K | $691.10M | $27.00K | $-691.58M | $-456.00K | 12 month · $7.67M | (m) | (m) |
| 2024-09-30 | $0.00 | $1.00K | $686.96M | $40.00K | $-710.46M | $-23.45M | 3 month · $2.00M | (m) | (m) |
| 2024-06-30 | $0.00 | $1.00K | $684.97M | $-4.00K | $-716.19M | $-31.23M | 3 month · $1.88M | (m) | (m) |
| 2024-03-31 | $0.00 | $1.00K | $677.99M | $-10.00K | $-709.66M | $-31.68M | 3 month · $1.91M | (m) | (m) |
| 2023-12-31 | $0.00 | $1.00K | $675.90M | $95.00K | $-723.45M | $-47.45M | 12 month · $8.56M | (m) | (m) |
| 2023-09-30 | (m) | $1.00K | $673.11M | $-63.00K | $-724.28M | $-51.24M | 3 month · $1.23M | (m) | (m) |
| 2023-06-30 | (m) | $1.00K | $642.21M | $35.00K | $-727.28M | $-85.03M | 3 month · $2.37M | (m) | (m) |
| 2023-03-31 | $0.00 | $1.00K | $639.53M | $26.00K | $-726.19M | $-86.64M | 3 month · $2.41M | (m) | (m) |
| 2022-12-31 | $0.00 | $1.00K | $637.12M | $10.00K | $-722.88M | $-85.75M | 12 month · $13.12M | (m) | (m) |
| 2022-09-30 | (m) | $1.00K | $634.36M | $-795.00K | $-714.10M | $-80.54M | 3 month · $2.69M | (m) | (m) |
| 2022-06-30 | (m) | $1.00K | $631.66M | $-1.16M | $-685.04M | $-54.54M | 3 month · $4.49M | (m) | (m) |
| 2022-03-31 | (m) | $1.00K | $626.72M | $-919.00K | $-655.54M | $-29.74M | 3 month · $3.37M | (m) | (m) |
| 2021-12-31 | (m) | $1.00K | $623.34M | $-242.00K | $-623.56M | $-459.00K | 12 month · $13.17M | (m) | (m) |
| 2021-09-30 | (m) | $1.00K | $619.12M | $52.00K | $-588.74M | $30.43M | 3 month · $3.16M | (m) | (m) |
| 2021-06-30 | (m) | $1.00K | $615.85M | $15.00K | $-557.76M | $58.11M | 3 month · $3.42M | (m) | (m) |
| 2021-03-31 | (m) | $1.00K | $611.73M | $-43.00K | $-531.02M | $80.67M | 3 month · $3.03M | (m) | (m) |
| 2020-12-31 | (m) | $1.00K | $499.96M | $-47.00K | $-507.69M | $-7.77M | 12 month · $14.79M | (m) | (m) |
| 2020-09-30 | (m) | $1.00K | $483.52M | $-47.00K | $-435.41M | $48.06M | 3 month · $3.84M | (m) | (m) |
| 2020-06-30 | (m) | $1.00K | $479.52M | $16.00K | $-420.70M | $58.83M | 3 month · $3.51M | (m) | (m) |
| 2020-03-31 | (m) | $1.00K | $474.45M | $336.00K | $-405.02M | $69.77M | 3 month · $4.01M | (m) | (m) |
| 2019-12-31 | (m) | $1.00K | $468.29M | $57.00K | $-442.87M | $25.47M | 12 month · $19.10M | (m) | (m) |
| 2019-09-30 | (m) | $1.00K | $463.77M | $110.00K | $-381.77M | $82.11M | 3 month · $4.34M | (m) | (m) |
| 2019-06-30 | (m) | $1.00K | $459.37M | $209.00K | $-358.08M | $101.50M | 3 month · $5.45M | (m) | (m) |
| 2019-03-31 | (m) | $1.00K | $451.61M | $73.00K | $-329.12M | $122.57M | 3 month · $5.19M | (m) | (m) |
| 2018-12-31 | (m) | $1.00K | $445.96M | $-93.00K | $-314.98M | $135.83M | 12 month · $16.88M | (m) | (m) |
| 2018-09-30 | (m) | $1.00K | $440.62M | $-208.00K | $-282.75M | $157.66M | 3 month · $4.41M | (m) | (m) |
| 2018-06-30 | (m) | $1.00K | $300.63M | $-178.00K | $-259.32M | $41.13M | 3 month · $4.16M | (m) | (m) |
| 2018-03-31 | (m) | $1.00K | $295.74M | $-228.00K | $-245.87M | $49.65M | 3 month · $3.69M | (m) | (m) |
| 2017-12-31 | (m) | $1.00K | $289.45M | $-94.00K | $-219.47M | $69.90M | 12 month · $11.29M | (m) | (m) |
| 2017-09-30 | (m) | $1.00K | $265.62M | $-61.00K | $-220.09M | $45.48M | (m) | (m) | (m) |
| 2017-06-30 | (m) | $1.00K | $262.19M | $-110.00K | $-209.84M | $52.24M | (m) | (m) | (m) |
| 2017-03-31 | (m) | $1.00K | $258.51M | $-100.00K | $-184.62M | $73.79M | (m) | (m) | (m) |
| 2016-12-31 | (m) | $1.00K | $254.87M | $-27.00K | $-176.37M | $78.48M | 12 month · $10.10M | (m) | (m) |
| 2016-09-30 | (m) | $1.00K | $251.75M | $6.00K | $-162.33M | $89.42M | (m) | (m) | (m) |
| 2016-06-30 | (m) | $1.00K | $248.78M | $80.00K | $-147.67M | $101.19M | (m) | (m) | (m) |
| 2016-03-31 | (m) | $1.00K | $246.26M | $30.00K | $-133.50M | $112.71M | (m) | (m) | (m) |
| 2015-12-31 | (m) | $1.00K | $243.69M | $-76.00K | $-117.47M | $126.07M | 12 month · $3.99M | (m) | 12 month · $3.80M |
| 2015-09-30 | (m) | $1.00K | (m) | $8.00K | $-105.98M | $-106.05M | (m) | (m) | (m) |
| 2014-12-31 | (m) | $1.00K | (m) | (m) | $-78.14M | $-78.54M | 12 month · $553.00K | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | $-44.28M | 12 month · $343.00K | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | $-26.05M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |